MB-CART19.1 in Refractory SLE

Conditions: SLE - Systemic Lupus Erythematosus Interventions: Biological: MB-CART19.1 Sponsors: Miltenyi Biomedicine GmbH Not yet recruiting

Source: ClinicalTrials.gov - January 3, 2024 Category: Research Source Type: clinical trials